Philip Cunningham
Overview
Explore the profile of Philip Cunningham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
718
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hengel B, Guy R, Casey D, Anderson L, Smith K, Andrewartha K, et al.
Med J Aust
. 2025 Jan;
222(4):172-178.
PMID: 39888019
No abstract available.
2.
Prestedge J, Ninan M, Phoeung C, Seang K, Young G, Khamphaphongphane B, et al.
Diagn Microbiol Infect Dis
. 2025 Jan;
111(3):116677.
PMID: 39818183
Background: Quality assurance programs (QAPs) are used to evaluate the analytical quality of a diagnostic test and provide feedback to improve quality processes in testing. Rapid diagnostic tests were used...
3.
Phoeung C, Prestedge J, Ninan M, Cunningham P, Bory S, Seang K, et al.
BMJ Open Qual
. 2025 Jan;
14(1).
PMID: 39762057
Rapid antigen diagnostic tests (Ag-RDTs) that quickly and accurately identify SARS-CoV-2 are an essential part of the COVID-19 response, but multiple factors can affect the validity of Ag-RDTs results. In...
4.
Applegate T, Causer L, Gow I, Alternetti N, Anderson L, Borgnolo B, et al.
Expert Rev Mol Diagn
. 2024 Dec;
:1-14.
PMID: 39719681
Introduction: Decentralized molecular testing for infectious disease diagnosis at the point-of-care (POC) is critical to address inequities in access to timely, informed health care. The COVID-19 pandemic accelerated the demand,...
5.
King J, Di Giallonardo F, Shaik A, McGregor S, Yeung J, Sivaruban T, et al.
J Int AIDS Soc
. 2024 Jul;
27(7):e26308.
PMID: 39034597
Introduction: New South Wales (NSW) has one of the world's highest uptake rates of HIV pre-exposure prophylaxis (PrEP). This uptake has been credited with sharp declines in HIV transmission, particularly...
6.
Carrington N, Conway A, Grebely J, Starr M, Catlett B, Stevens A, et al.
BMC Infect Dis
. 2024 Jan;
24(1):137.
PMID: 38287234
Background: Dried blood spot (DBS) testing provides an alternative to phlebotomy and addresses barriers to accessing healthcare experienced by some key populations. Large-scale evaluations of DBS testing programs are needed...
7.
Grebely J, Matthews S, Causer L, Feld J, Cunningham P, Dore G, et al.
Expert Rev Mol Diagn
. 2024 Jan;
24(3):177-191.
PMID: 38173401
Introduction: Progress toward hepatitis C virus (HCV) elimination is impeded by low testing and treatment due to the current diagnostic pathway requiring multiple visits leading to loss to follow-up. Point-of-care...
8.
Conway A, Stevens A, Murray C, Prain B, Power C, McNulty A, et al.
Open Forum Infect Dis
. 2023 Nov;
10(11):ofad517.
PMID: 38023551
Background: Dried blood spot (DBS) testing for hepatitis C virus (HCV) RNA provides a sampling option that avoids venepuncture and can be carried out in a nonclinical setting. Large-scale evaluations...
9.
Phetsouphanh C, Khoo W, Jackson K, Klemm V, Howe A, Aggarwal A, et al.
Front Immunol
. 2022 Dec;
13:1032911.
PMID: 36544780
Background: Long-term immunity to SARS-CoV-2 infection, including neutralizing antibodies and T cell-mediated immunity, is required in a very large majority of the population in order to reduce ongoing disease burden....
10.
Lynch K, Apadinuwe S, Lambert S, Hillgrove T, Starr M, Catlett B, et al.
PLoS Negl Trop Dis
. 2022 Apr;
16(4):e0010275.
PMID: 35439248
Background: The epidemiology of trachoma in several Pacific Islands differs from other endemic settings, in that there is a high prevalence of clinical signs of trachoma, particularly trachomatous inflammation-follicular (TF),...